Global Hyperactivation of Enhancers Stabilizes Human and Mouse Naive Pluripotency Through Inhibition of CDK8/19 Mediator Kinases

Pluripotent stem cells (PSCs) transition between cell states in vitro, reflecting developmental changes in the early embryo. PSCs can be stabilized in the naive state by blocking extracellular differentiation stimuli, particularly FGF-MEK signalling. Here, we report that multiple features of the naive state in human and mouse PSCs can be recapitulated without affecting FGF-MEK signalling or global DNA methylation. Mechanistically, chemical inhibition of CDK8 and CDK19 (hereafter CDK8/19) kinases removes their ability to repress the Mediator complex at enhancers. CDK8/19 inhibition therefore increases Mediator-driven recruitment of RNA polymerase II (RNA Pol II) to promoters and enhancers. This efficiently stabilizes the naive transcriptional program and confers resistance to enhancer perturbation by BRD4 inhibition. Moreover, naive pluripotency during embryonic development coincides with a reduction in CDK8/19. We conclude that global hyperactivation of enhancers drives naive pluripotency, and this can be achieved in vitro by inhibiting CDK8/19 kinase activity. These principles may apply to other contexts of cellular plasticity.

Citing Articles

Mediator kinase inhibition drives myometrial stem cell differentiation and the uterine fibroid phenotype through super-enhancer reprogramming.

Khadka S, Lukas B, Sun C, Muralimanoharan S, Shanmugasundaram K, Khosh A J Mol Med (Berl). 2025; 103(3):311-326.

PMID: 39904883 PMC: 11880082. DOI: 10.1007/s00109-025-02517-0.

Mediator kinase inhibition drives myometrial stem cell differentiation and the uterine fibroid phenotype through super-enhancer reprogramming.

Khadka S, Lukas B, Sun C, Muralimanoharan S, Shanmugasundaram K, Khosh A Res Sq. 2025; .

PMID: 39764110 PMC: 11702794. DOI: 10.21203/rs.3.rs-5125876/v1.

Transposable element activity captures human pluripotent cell states.

Levin-Ferreyra F, Kodali S, Cui Y, Pashos A, Pessina P, Brumbaugh J EMBO Rep. 2024; 26(2):329-352.

PMID: 39668246 PMC: 11772670. DOI: 10.1038/s44319-024-00343-y.

Deficiency of FABP7 Triggers Premature Neural Differentiation in Idiopathic Normocephalic Autism Organoids.

Han X, He Y, Wang Y, Hu W, Chu C, Huang L Adv Sci (Weinh). 2024; 12(2):e2406849.

PMID: 39556706 PMC: 11727249. DOI: 10.1002/advs.202406849.

Cdk8 and Hira mutations trigger X chromosome elimination in naive female hybrid mouse embryonic stem cells.

Halter K, Chen J, Priklopil T, Monfort A, Wutz A Chromosome Res. 2024; 32(4):12.

PMID: 39390295 PMC: 11467062. DOI: 10.1007/s10577-024-09756-w.

References

Heinz S, Romanoski C, Benner C, Glass C . The selection and function of cell type-specific enhancers. Nat Rev Mol Cell Biol. 2015; 16(3):144-54. PMC: 4517609. DOI: 10.1038/nrm3949. View

Hnisz D, Abraham B, Lee T, Lau A, Saint-Andre V, Sigova A . Super-enhancers in the control of cell identity and disease. Cell. 2013; 155(4):934-47. PMC: 3841062. DOI: 10.1016/j.cell.2013.09.053. View

Whyte W, Orlando D, Hnisz D, Abraham B, Lin C, Kagey M . Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013; 153(2):307-19. PMC: 3653129. DOI: 10.1016/j.cell.2013.03.035. View

Allen B, Taatjes D . The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol. 2015; 16(3):155-66. PMC: 4963239. DOI: 10.1038/nrm3951. View

Jeronimo C, Robert F . The Mediator Complex: At the Nexus of RNA Polymerase II Transcription. Trends Cell Biol. 2017; 27(10):765-783. DOI: 10.1016/j.tcb.2017.07.001. View

Hnisz D, Shrinivas K, Young R, Chakraborty A, Sharp P . A Phase Separation Model for Transcriptional Control. Cell. 2017; 169(1):13-23. PMC: 5432200. DOI: 10.1016/j.cell.2017.02.007. View

Chen H, Li C, Peng X, Zhou Z, Weinstein J, Liang H . A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell. 2018; 173(2):386-399.e12. PMC: 5890960. DOI: 10.1016/j.cell.2018.03.027. View

Clark A, Oldenbroek M, Boyer T . Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol. 2015; 50(5):393-426. PMC: 4928375. DOI: 10.3109/10409238.2015.1064854. View

Poss Z, Ebmeier C, Odell A, Tangpeerachaikul A, Lee T, Pelish H . Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016; 15(2):436-50. PMC: 4833653. DOI: 10.1016/j.celrep.2016.03.030. View

10.

Knuesel M, Meyer K, Bernecky C, Taatjes D . The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev. 2009; 23(4):439-51. PMC: 2648653. DOI: 10.1101/gad.1767009. View

11.

van de Peppel J, Kettelarij N, van Bakel H, Kockelkorn T, van Leenen D, Holstege F . Mediator expression profiling epistasis reveals a signal transduction pathway with antagonistic submodules and highly specific downstream targets. Mol Cell. 2005; 19(4):511-22. DOI: 10.1016/j.molcel.2005.06.033. View

12.

Pelish H, Liau B, Nitulescu I, Tangpeerachaikul A, Poss Z, Da Silva D . Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature. 2015; 526(7572):273-276. PMC: 4641525. DOI: 10.1038/nature14904. View

13.

Gonzalez D, Hamidi N, Del Sol R, Benschop J, Nancy T, Li C . Suppression of Mediator is regulated by Cdk8-dependent Grr1 turnover of the Med3 coactivator. Proc Natl Acad Sci U S A. 2014; 111(7):2500-5. PMC: 3932902. DOI: 10.1073/pnas.1307525111. View

14.

Bancerek J, Poss Z, Steinparzer I, Sedlyarov V, Pfaffenwimmer T, Mikulic I . CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity. 2013; 38(2):250-62. PMC: 3580287. DOI: 10.1016/j.immuni.2012.10.017. View

15.

Galbraith M, Donner A, Espinosa J . CDK8: a positive regulator of transcription. Transcription. 2011; 1(1):4-12. PMC: 3035184. DOI: 10.4161/trns.1.1.12373. View

16.

Hackett J, Surani M . Regulatory principles of pluripotency: from the ground state up. Cell Stem Cell. 2014; 15(4):416-430. DOI: 10.1016/j.stem.2014.09.015. View

17.

Nichols J, Smith A . Naive and primed pluripotent states. Cell Stem Cell. 2009; 4(6):487-92. DOI: 10.1016/j.stem.2009.05.015. View

18.

Galonska C, Ziller M, Karnik R, Meissner A . Ground State Conditions Induce Rapid Reorganization of Core Pluripotency Factor Binding before Global Epigenetic Reprogramming. Cell Stem Cell. 2015; 17(4):462-70. PMC: 4592414. DOI: 10.1016/j.stem.2015.07.005. View

19.

Weinberger L, Ayyash M, Novershtern N, Hanna J . Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol. 2016; 17(3):155-69. DOI: 10.1038/nrm.2015.28. View

20.

Wu J, Izpisua Belmonte J . Dynamic Pluripotent Stem Cell States and Their Applications. Cell Stem Cell. 2015; 17(5):509-25. DOI: 10.1016/j.stem.2015.10.009. View